Optomap system eases diabetic retinopathy assessment

NEW YORK (Reuters Health) - For grading diabetic retinopathy (DR) and clinically significant macular edema (CSME), the Optomap Panoramic 200 (Optos) imaging device offers advantages over standard methods, German researchers say.

Full Story →